The prevalence of frailty among acute stroke patients, and evaluation of method of assessment.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 12 4 2019
medline: 27 12 2019
entrez: 12 4 2019
Statut: ppublish

Résumé

We aimed to determine prevalence of pre-stroke frailty in acute stroke and describe validity of a Frailty Index-based assessment. Cross-sectional. Single UK urban teaching hospital. Consecutive acute stroke unit admissions, recruited in four waves (May 2016-August 2018). We performed the assessments within first week and attempted to include all admissions. Our primary measure was a Frailty Index, based on cumulative disorders. A proportion of participants were also assessed with the 'Frail non-disabled' questionnaire. We evaluated concurrent validity of Frailty Index against variables associated with frailty in non-stroke populations. We described predictive validity of Frailty Index for stroke severity and delirium. We described convergent validity, quantifying agreement between frailty assessments and a measure of pre-stroke disability (modified Rankin Scale) using kappa statistics and correlations. We included 546 patients. A Frailty Index-defined frailty syndrome was observed in 427 of 545 patients (78%), of whom, 151 (28%) had frank frailty and 276 (51%) were pre-frail. Phenotypic frailty was observed in 72 of 258 patients (28%). We demonstrated concurrent validity via significant associations with all variables (all Frailty is present in around one in four patients with acute stroke; if pre-frailty is included, then a frailty syndrome is seen in three out of four patients. The Frailty Index is a valid measure of frailty in stroke; however, there is little agreement between this scale and other measurements of frailty.

Identifiants

pubmed: 30971115
doi: 10.1177/0269215519841417
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1688-1696

Auteurs

Martin Taylor-Rowan (M)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Gillian Cuthbertson (G)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Ruth Keir (R)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Robert Shaw (R)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Bogna Drozdowska (B)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Emma Elliott (E)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

David Stott (D)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Terence J Quinn (TJ)

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH